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Abstract
Antibiotic resistance monitoring is of paramount importance in the face of this on-
going global epidemic. Deep learning models trained with traditional optimization
algorithms (e.g. Adam, SGD) provide poor posterior estimates when tested against
out-of-distribution (OoD) antibiotic resistant/non-resistant genes. In this paper,
we introduce a deep learning model trained with Stochastic Gradient Langevin
Dynamics (SGLD) to classify antibiotic resistant genes. The model provides bet-
ter uncertainty estimates when tested against OoD data compared to traditional
optimization methods such as Adam.
1 Introduction
Antibiotic resistance is a global scourge that is taking an increasing toll in mortality and morbidity, in
both nosocomial and community acquired infections[1, 2]. A growing number of once easily treatable
infectious diseases such as tuberculosis, gonorrhea, and pneumonia are becoming harder to treat as
the scope of effective drugs is shrinking. The CDC estimates that 2,000,000 illnesses and 23,000
people die annually from antibiotic resistance in the US alone[3]. The overuse of antibiotics in health
care and agriculture is exacerbating the problem to the point that the World Health Organization is
considering antibiotic resistance “one of the biggest threats to global health, food security and human
development today”. Identifying genes associated with antibiotic resistance is an important first step
towards dealing with the problem[4], and providing a narrow-spectrum treatment, targeted solely
against the types of resistance displayed. This statement is especially true when dealing with genes
acquired from human or environmental metagenomic samples[5]. A rapid identification of the class
of antibiotic resistance that may exist in a given environmental or clinical microbiome sample can
provide immediate guidance to treatment and prevention.
In this study, we developed a deep neural network that can predict antibiotic resistance into 15
classes from protein sequences. It can be useful in identifying metagenomic sample resistance
for the purpose of providing a focused drug treatment. Traditional methods [6, 7, 8] to identify
antibiotic-resistant genes usually take a alignment based best-hit approach which causes the methods
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to produce many false negatives [9]. Recently, a deep learning based approach was developed that
used normalized bit scores as features that were acquired after aligning against known antibiotic
resistant genes [9]. In contrast, our model only uses the raw protein sequence as its input. At the
same time, neural networks are known for providing high confidence scores on inputs that are from a
different probability distribution than the model was trained on [10, 11]. This can result in disastrous
consequences in sensitive applications such as health care or self-driving systems. Here, we develop
two deep learning models that were trained with ADAM and SGLD. Both models give significant
accuracy on the test set in terms of predicting antibiotic resistance solely from the protein sequence.
But we show that the model trained with SGLD is better equipped to predict OoD data i.e., it assigns
a low probability to sequences from proteins that are not related to antibiotic-resistance or are from
classes that were not included in training.
2 Dataset and Model
Dataset We used the dataset curated in the DeepArg study [9]. Briefly, The dataset was created
from the CARD [12], ARDB [13] and UNIPROT [14] databases with a combination of computational
and manual curation. The original dataset has 14974 protein sequences that are resistant to 34
different antibiotics (our classes in the multi-class classification task). There were 19 classes that had
training samples of 11 sequences or less. We discarded these classes and were left with 15 classes
with a total of 14907 protein sequences.
Model We used a self-attention based sentence embedding model introduced in [15]. For input,
we represented each amino acid in a protein sequence as a size 10 embedding that was randomly
initialized, and then trained end-to-end. We used one single layer of LSTM with 64 units and a
dropout value of 0.7. Following that is the self-attention part which we can think of as a feed-forward
neural network with one hidden layer of 600 units. This network takes the output from the LSTM
layer as input, and produces an output of size 100. We weighted this output with a softmax layer
which outputs our attentions. We multiplied the outputs of the LSTM layer with these attentions to
get a weighted view of the LSTM hidden states. The result of this multiplication became our sentence
embedding for that specific protein sequence.
Optimization Typically, neural networks are trained with optimization methods such as Stochastic
gradient descent (SGD) [16] or its variants such as Adam [17], Adagrad [18], RMSprop [19] etc. In
SGD, for each iteration a mini-batch from the dataset is used to update the parameters of the neural
network. For each iteration t, training data Xt = {xt1, ..., xtn} is provided, and for parameters θ, the
update ∆θt is:
∆θt =
t
2
(
∇ log p(θt) + N
n
n∑
i=1
∇ log p(xti|θt)
)
(1)
At the same time, SGD or its variants do not capture parameter uncertainty. In contrast, Bayesian
approaches such as Markov Chain Monte Carlo (MCMC) [20] techniques do capture uncertainty
estimates. One such class of techniques are Langevin dynamics [21] which inject Gaussian noise into
Equation 1 so that the parameters do not collapse into the Maximum a posteriori (MAP) solution:
∆θt =

2
(
∇ log p(θt) + N
n
n∑
i=1
∇ log p(xti|θt)
)
+ ηt (2)
where, ηt ∼ N(0, )
However, MCMC techniques require that the algorithm go over the entire dataset per iteration before
making a parameter update. This slows down the model training process, and also requires huge
computational costs. To remove this problem, Stochastic Gradient Langevin Dynamics (SGLD) was
introduced [22], which combined the best of both worlds i.e. inserting Gaussian noise into each
mini-batch of training data. In SGLD, during each iteration for SGD, Gaussian noise is injected
which has a variance of the step-size t:
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Table 1: Comparison between SGLD and ADAM trained models for 15 different classes of antibiotic
resistance.
SGLD trained model ADAM trained model
Antibiotics Precision Recall F1 Precision Recall F1 Number of data pointsin Test set
Multidrug 0.68 0.81 0.74 0.84 0.92 0.88 109
Beta Lactam 0.97 0.93 0.95 0.99 0.96 0.98 519
Aminoglycoside 0.82 0.82 0.82 0.90 0.97 0.93 87
Rifampin 1.00 0.67 0.80 1.00 0.67 0.80 3
Tetracycline 0.68 0.70 0.69 0.86 0.70 0.78 27
Quinolone 0.75 0.92 0.83 0.80 0.92 0.86 13
Macrolide
lincosamide streptogramin 0.93 0.85 0.89 0.95 0.94 0.95 111
Fosfomycin 0.90 0.93 0.92 1.00 0.93 0.96 29
Polymyxin 0.97 0.97 0.97 1.00 0.99 0.99 90
Chloramphenicol 0.78 0.83 0.80 0.98 0.89 0.93 47
Bacitracin 0.99 0.96 0.98 0.99 0.98 0.99 421
Kasugamycin 1.00 1.00 1.00 1.00 1.00 1.00 3
Trimethoprim 0.83 0.62 0.71 0.78 0.88 0.82 8
Sulfonamide 1.00 1.00 1.00 1.00 1.00 1.00 2
Glycopeptide 0.49 0.82 0.61 0.53 0.91 0.67 22
Overall 0.92 0.91 0.91 0.96 0.95 0.96
∆θt =
t
2
(
∇ log p(θt) + N
n
n∑
i=1
∇ log p(xti|θt)
)
+ ηt (3)
where, ηt ∼ N(0, t)
This injection of Gaussian noise has an advantageous side-effect, as it also provides a better calibration
of confidence scores of predictions on OoD data. For example, [10] showed that an SGLD trained
neural network provides low confidence scores when trained on the MNIST [23] dataset but tested
on the NotMNIST dataset [24]; whereas an SGD trained neural network still naively provides high
confidence scores. We used SGLD to train a neural network to classify protein sequences into their
antibiotic resistance classes. In the experiment section, we show that an SGLD trained network
provides low confidence scores when predicting on OoD protein sequences while an ADAM trained
model still provides high confidence scores.
3 Experiment
The model that is trained with ADAM has the same self-attention architecture as the model used for
SGLD training except it has 3 bi-directional LSTM layers. We used a learning rate of 0.001 with a
weight decay value of 0.0001.
We divided our dataset into a 70/20/10% training, validation, and test set split. We trained our model
with SGLD on the training dataset, and tuned the hyper-parameters by checking the performance on
the validation dataset. Testing on the test dataset was done only once.
Table 1 shows the performance of both SGLD and ADAM trained models on the test set in terms of
Precision, Recall and F1 for each class and overall. We show that overall the ADAM trained model is
performing better than the SGLD trained model.
In the next step, we tested both models on OoD samples. For this we used the 19 classes of antibiotic
resistant classes we did not include in our dataset used for training and testing. These 19 classes have
a total of 67 protein sequences. We also used about 19,000 human genes that we can confidently
assume that these are not classified as antibiotic resistant.
Before testing on these sequences, our expectation is that an ideal model trained on a different
set of classes (the 15 antibiotic classes used in training and testing in our case) should provide
low probabilities for its prediction on out-of-class sequences. The model should also provide low
probabilities for human genes that are not antibiotic resistant. Figure 1 shows the distribution of
probability scores of predictions for both the SGLD and ADAM trained model on these sequences.
We can see from the figure that in both cases the probability distribution for SGLD is centered around
0.5 whereas for ADAM the distribution is heavily right skewed. The ADAM trained model is still
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ral networks predict antibiotic resistance with
a much lower probability.
Figure 1: Probabilities assigned to predictions by both SGLD and ADAM trained models. The SGLD trained
method predicts low probability for antibiotic resistance, both for classes not trained on (a) , and for genes not
associated with antibiotic resistance (b).
predicting these OoD sequences to be one of the 15 classes it was trained on with high confidence. In
contrast, the SGLD model is conveying its uncertainty over its predictions.
4 Discussion
In this study we applied a training optimization method for neural networks which calibrates the
prediction probability scores such that OoD samples are assigned low probabilities. We used
this SGLD trained neural network for a multi-class classification task of antibiotic resistance type
classification from protein sequences. We trained our neural network on 15 classes of antibiotic
resistant proteins. We also trained another ADAM trained neural network on these same 15 classes of
antibiotic resistant proteins. The overall F1 score for the ADAM trained model (96%) was higher
than the SGLD trained model (91%) model. Yet, when we tested both neural networks on two
datasets of protein sequences that we know either belong to classes of antibiotic resistance that were
not part of our training and testing or are not antibiotic resistance associated, the ADAM trained
model still predicted them to be of the 15 classes with a high probability distribution. In contrast, for
the SGLD trained model provided predictions with a lower probability distribution for the proteins
not associated with antibiotic resistance. We hypothesize that the Gaussian Noise introduced in
the SGLD training scheme impedes the neural networks to completely collapse on the Maximum
Likelihood solution. That may also be the reason that training a neural network with SGLD towards
convergence is difficult when compared with a neural network trained with ADAM and weight decay.
However, SGLD lets a discriminative model detect OoD data points, and consequently provide lower
probabilities in its predictions for them. This is an important property, especially when we consider
the open world problem in biology where for any classification task it is hard to collect negative
training samples for training the machine learning algorithm [25]. One avenue of future research is to
investigate how to increase the accuracy of SGLD like training optimization methods. This might
involve changing the structure of the noise we are introducing.
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